Viewing Study NCT02384967


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-04-22 @ 4:16 AM
Study NCT ID: NCT02384967
Status: COMPLETED
Last Update Posted: 2017-01-24
First Post: 2015-02-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients
Sponsor: ANRS, Emerging Infectious Diseases
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module